{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:59:40Z","timestamp":1740135580593,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kyungpook National University Dental Hospital Institute for Dental Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-024-04873-8","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T13:28:11Z","timestamp":1726666091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NKG2D (Natural Killer Group 2, Member D) ligand expression and ameloblastoma recurrence: a retrospective immunohistological pilot study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4244-1985","authenticated-orcid":false,"given":"Mee-seon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4009-6321","authenticated-orcid":false,"given":"Soeun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3450-865X","authenticated-orcid":false,"given":"Hyeon Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7305-4144","authenticated-orcid":false,"given":"Hyun-Su","family":"Ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7108-1384","authenticated-orcid":false,"given":"Ah-Reum","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-1127","authenticated-orcid":false,"given":"Eun Ji","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-0418","authenticated-orcid":false,"given":"Jin Song","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1366-5640","authenticated-orcid":false,"given":"Jae-Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4741-8722","authenticated-orcid":false,"given":"Jiyoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"4873_CR1","first-page":"177","volume":"54","author":"H Kubo","year":"2020","unstructured":"Kubo H, Motohashi T, Nakano K, Horii K, Fujii T, Shoju Y, et al. Treatment of ameloblastoma and its recurrence at a single institution over a 23-year period. J Osaka Dent Univ. 2020;54:177\u201381.","journal-title":"J Osaka Dent Univ"},{"key":"4873_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.anorl.2016.09.004","volume":"134","author":"A Laborde","year":"2017","unstructured":"Laborde A, Nicot R, Wojcik T, Ferri J, Raoul G. Ameloblastoma of the jaws: management and recurrence rate. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:7\u201311.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"4873_CR3","first-page":"e27734","volume":"14","author":"S Ghai","year":"2022","unstructured":"Ghai S. Ameloblastoma: an updated narrative review of an enigmatic tumor. Cureus. 2022;14:e27734.","journal-title":"Cureus"},{"key":"4873_CR4","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00405-015-3631-8","volume":"273","author":"AC McClary","year":"2016","unstructured":"McClary AC, West RB, McClary AC, Pollack JR, Fischbein NJ, Holsinger CF, et al. Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol. 2016;273:1649\u201361.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"4873_CR5","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ijom.2019.04.008","volume":"48","author":"SW Au","year":"2019","unstructured":"Au SW, Li KY, Choi WS, Su YX. Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study. Int J Oral Maxillofac Surg. 2019;48:1300\u20136.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4873_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","volume":"117","author":"L Moretta","year":"2011","unstructured":"Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, Moretta A. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood. 2011;117:764\u201371.","journal-title":"Blood"},{"key":"4873_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.0300-9475.2004.01475.x","volume":"60","author":"E Backstr\u00f6m","year":"2004","unstructured":"Backstr\u00f6m E, Kristensson K, Ljunggren H-G. Activation of natural killer cells: underlying molecular mechanisms revealed. Scand J Immunol. 2004;60:14\u201322.","journal-title":"Scand J Immunol"},{"key":"4873_CR8","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/ijc.28775","volume":"136","author":"A L\u00f3pez-Soto","year":"2015","unstructured":"L\u00f3pez-Soto A, Huergo-Zapico L, Acebes-Huerta A, Villa-Alvarez M, Gonzalez S. NKG2D signaling in cancer immunosurveillance. Int J Cancer. 2015;136:1741\u201350.","journal-title":"Int J Cancer"},{"key":"4873_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coi.2018.02.004","volume":"51","author":"P Dhar","year":"2018","unstructured":"Dhar P, Wu JD. NKG2D and its ligands in cancer. Curr Opin Immunol. 2018;51:55\u201361.","journal-title":"Curr Opin Immunol"},{"key":"4873_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jhep.2011.06.017","volume":"56","author":"H Kamimura","year":"2012","unstructured":"Kamimura H, Yamagiwa S, Tsuchiya A, Takamura M, Matsuda Y, Ohkoshi S, et al. Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence. J Hepatol. 2012;56:381\u20138.","journal-title":"J Hepatol"},{"key":"4873_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2407-12-24","volume":"12","author":"EM de Kruijf","year":"2012","unstructured":"de Kruijf EM, Sajet A, van Nes JGH, Putter H, Smit VTHBM, Eagle RA, et al. NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study. BMC Cancer. 2012;12:24.","journal-title":"BMC Cancer"},{"key":"4873_CR12","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1158\/1078-0432.CCR-09-0991","volume":"15","author":"RW McGilvray","year":"2009","unstructured":"McGilvray RW, Eagle RA, Watson NFS, Al-Attar A, Ball G, Jafferji I, et al. NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting. Clin Cancer Res. 2009;15:6993\u20137002.","journal-title":"Clin Cancer Res"},{"key":"4873_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3389\/fonc.2020.00971","volume":"10","author":"NJW Easom","year":"2020","unstructured":"Easom NJW, Marks M, Jobe D, Gillmore R, Meyer T, Maini MK, et al. ULBP1 is elevated in human hepatocellular carcinoma and predicts outcome. Front Oncol. 2020;10:971.","journal-title":"Front Oncol"},{"key":"4873_CR14","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1158\/2326-6066.CIR-19-0026","volume":"7","author":"B Sun","year":"2019","unstructured":"Sun B, Yang D, Dai H, Liu X, Jia R, Cui X, et al. Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T cells. Cancer Immunol Res. 2019;7:1813\u201323.","journal-title":"Cancer Immunol Res"},{"key":"4873_CR15","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/bjc.2017.79","volume":"116","author":"H Ghadially","year":"2017","unstructured":"Ghadially H, Brown L, Lloyd C, Lewis L, Lewis A, Dillon J, et al. MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. Br J Cancer. 2017;116:1208\u201317.","journal-title":"Br J Cancer"},{"key":"4873_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","volume":"9","author":"N Fedchenko","year":"2014","unstructured":"Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue \u2013 a review. Diagn Pathol. 2014;9:221.","journal-title":"Diagn Pathol"},{"key":"4873_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.21147\/j.issn.1000-9604.2017.03.04","volume":"29","author":"R Yang","year":"2017","unstructured":"Yang R, Liu Z, Gokavarapu S, Peng C, Ji T, Cao W. Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma. Chin J Cancer Res. 2017;29:189\u201395.","journal-title":"Chin J Cancer Res"},{"key":"4873_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710\u20138.","journal-title":"Am J Epidemiol"},{"key":"4873_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0901-5027(98)80037-4","volume":"27","author":"AA Olaltan","year":"1998","unstructured":"Olaltan AA, Arole G, Adekeye EO. Recurrent ameloblastoma of the jaws: a follow-up study. Int J Oral Maxillofac Surg. 1998;27:456\u201360.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4873_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijom.2006.11.003","volume":"36","author":"J Hong","year":"2007","unstructured":"Hong J, Yun PY, Chung IH, Myoung H, Suh JD, Seo B-M, et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg. 2007;36:283\u20138.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4873_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10006-018-0715-9","volume":"22","author":"Y Slusarenko da Silva","year":"2018","unstructured":"Slusarenko da Silva Y, Tartaroti NA, Sendyk DI, Deboni MCZ, Nacl\u00e9rio-Homem M. Da G. is conservative surgery a better choice for the solid\/multicystic ameloblastoma than radical surgery regarding recurrence? A systematic review. Oral Maxillofac Surg. 2018;22:349\u201356.","journal-title":"Oral Maxillofac Surg"},{"key":"4873_CR22","doi-asserted-by":"publisher","first-page":"2148086","DOI":"10.1155\/2022\/2148086","volume":"2022","author":"A Hresko","year":"2022","unstructured":"Hresko A, Palyvoda R, Burtyn O, Chepurnyi Y, Kopchak A, Helder M, et al. Recurrent Ameloblastoma: clinical manifestation and disease-free survival rate. J Oncol. 2022;2022:2148086.","journal-title":"J Oncol"},{"key":"4873_CR23","first-page":"2064","volume":"9","author":"H Liu","year":"2019","unstructured":"Liu H, Wang S, Xin J, Wang J, Yao C, Zhang Z. Role of NKG2D and its ligands in cancer immunotherapy. Am J Cancer Res. 2019;9:2064\u201378.","journal-title":"Am J Cancer Res"},{"key":"4873_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.smim.2017.08.002","volume":"31","author":"KJ Malmberg","year":"2017","unstructured":"Malmberg KJ, Carlsten M, Bj\u00f6rklund A, Sohlberg E, Bryceson YT, Ljunggren HG. Natural killer cell-mediated immunosurveillance of human cancer. Semin Immunol. 2017;31:20\u20139.","journal-title":"Semin Immunol"},{"key":"4873_CR25","doi-asserted-by":"publisher","first-page":"e926395","DOI":"10.12659\/MSM.926395","volume":"26","author":"S Jeon","year":"2020","unstructured":"Jeon S, Kim HK, Kwon JY, Baek SH, Ri HS, Choi HJ, et al. Role of Sevoflurane on Natural Killer Group 2, Member D-Mediated Immune Response in Non-small-cell Lung Cancer: an in Vitro Study. Med Sci Monit. 2020;26:e926395.","journal-title":"Med Sci Monit"},{"key":"4873_CR26","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3389\/fimmu.2018.01808","volume":"9","author":"S Sheppard","year":"2018","unstructured":"Sheppard S, Ferry A, Guedes J, Guerra N. The paradoxical role of NKG2D in Cancer Immunity. Front Immunol. 2018;9:1808.","journal-title":"Front Immunol"},{"key":"4873_CR27","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3389\/fimmu.2018.02040","volume":"9","author":"D Schmiedel","year":"2018","unstructured":"Schmiedel D, Mandelboim O. NKG2D ligands-critical targets for Cancer Immune escape and therapy. Front Immunol. 2018;9:2040.","journal-title":"Front Immunol"},{"key":"4873_CR28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/biology12081079","volume":"12","author":"G Tan","year":"2023","unstructured":"Tan G, Spillane KM, Maher J. The role and regulation of the NKG2D\/NKG2D ligand system in Cancer. Biology. 2023;12:1079.","journal-title":"Biology"},{"key":"4873_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/v8040095","volume":"8","author":"Y Ma","year":"2016","unstructured":"Ma Y, Li X, Kuang E. Viral evasion of natural killer cell activation. Viruses. 2016;8:95.","journal-title":"Viruses"},{"key":"4873_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cancers15020485","volume":"15","author":"S Pati","year":"2023","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer: a current overview of Epidemiology, Pathogenesis, outcomes, and management. Cancers. 2023;15:485.","journal-title":"Cancers"},{"key":"4873_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s12630-019-01330-x","volume":"66","author":"A Yap","year":"2019","unstructured":"Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B, Wigmore T, et al. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth. 2019;66:546\u201361.","journal-title":"Can J Anaesth"},{"key":"4873_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jclinane.2017.08.001","volume":"42","author":"S Soltanizadeh","year":"2017","unstructured":"Soltanizadeh S, Degett TH, G\u00f6genur I. Outcomes of cancer surgery after inhalational and intravenous anesthesia: a systematic review. J Clin Anesth. 2017;42:19\u201325.","journal-title":"J Clin Anesth"},{"key":"4873_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4097\/kja.23323","volume":"76","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Jeon S, Lee HJ, Bae J, Ri HS, Hong JM, et al. Effects of sevoflurane on metalloproteinase and natural killer group 2, member D (NKG2D) ligand expression and natural killer cell-mediated cytotoxicity in breast cancer: an in vitro study. Korean J Anesthesiol. 2023;76:627\u201339.","journal-title":"Korean J Anesthesiol"},{"key":"4873_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/odi.13031","volume":"26","author":"FN Hendra","year":"2020","unstructured":"Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, et al. Global incidence and profile of ameloblastoma: a systematic review and meta-analysis. Oral Dis. 2020;26:12\u201321.","journal-title":"Oral Dis"},{"key":"4873_CR35","unstructured":"Food and Drug Administration. Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only. Guidance for Industry and Food and Drug Administration Staff. USA: Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Center for Biologics Evaluation and Research Center for Drug Evaluation and Research. 2013 https:\/\/www.fda.gov\/files\/medical%20devices\/published\/Distribution-of-In-Vitro-Diagnostic-Products-Labeled-for-Research-Use-Only-or-Investigational-Use-Only---Guidance-for Industry-and-FDA-Staff.pdf [Date assessed: January 2, 2024]."},{"key":"4873_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42047-019-0041-z","volume":"2","author":"AMH Cadavid","year":"2019","unstructured":"Cadavid AMH, Araujo JP, Coutinho-Camillo CM, Bologna S, Junior CAL, Louren\u00e7o SV. Ameloblastomas: current aspects of the new WHO classification in an analysis of 136 cases. Surg Experimental Pathol. 2019;2:1\u20136.","journal-title":"Surg Experimental Pathol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-024-04873-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:50:25Z","timestamp":1726753825000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-024-04873-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4873"],"URL":"https:\/\/doi.org\/10.1186\/s12903-024-04873-8","relation":{},"ISSN":["1472-6831"],"issn-type":[{"type":"electronic","value":"1472-6831"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by Institutional Review Board (IRB) of Kyungpook National University Hospital, Deagu, Korea (IRB No. 2023-05-010) and has been conducted in full accordance with the Declaration of Helsinki. The study was retrospective therefore the Institutional Review Board (IRB) of Kyungpook National University Hospital, Deagu, Korea (IRB No. 2023-05-010) waived the need for written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1102"}}